{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:31:59Z","timestamp":1786120319774,"version":"build-2736575974"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1097\/jcp.0b013e31823f3c43","type":"journal-article","created":{"date-parts":[[2011,12,24]],"date-time":"2011-12-24T11:48:34Z","timestamp":1324727314000},"page":"31-35","source":"Crossref","is-referenced-by-count":28,"title":["All-Cause Mortality and Medication Risk Factors in Schizophrenia"],"prefix":"10.1097","volume":"32","author":[{"given":"Diederik","family":"Tenback","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bram","family":"Pijl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo","family":"Smeets","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jim van","family":"Os","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter van","family":"Harten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-6-20210128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.schres.2008.04.011","article-title":"Schizophrenia, just the facts what we know in 2008. 2. Epidemiology and etiology.","volume":"102","author":"Tandon","year":"2008","journal-title":"Schizophr Res"},{"key":"R2-6-20210128","first-page":"1123","article-title":"A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time Arch Gen Psychiatry.","volume":"64","author":"Saha","year":"2007","journal-title":""},{"key":"R3-6-20210128","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S0140-6736(09)60742-X","article-title":". 11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study).","volume":"374","author":"Tiihonen","year":"2009","journal-title":"Lancet"},{"issue":"suppl 4","key":"R4-6-20210128","first-page":"8","article-title":"Antipsychotic medications: metabolic and cardiovascular risk.","volume":"68","author":"Newcomer","year":"2007","journal-title":"J Clin Psychiatry"},{"key":"R5-6-20210128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.schres.2009.05.018","article-title":"Influence of antipsychotics on mortality in schizophrenia: systematic review.","volume":"113","author":"Weinmann","year":"2009","journal-title":"Schizophr Res"},{"key":"R6-6-20210128","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1176\/appi.ajp.158.3.360","article-title":"Does fast dissociation from the dopamine d(2) receptor explain the action of atypical antipsychotics a new hypothesis.","volume":"158","author":"Kapur","year":"2001","journal-title":"Am J Psychiatry"},{"key":"R7-6-20210128","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.4088\/JCP.v66n0907","article-title":". Effects of antipsychotic treatment on tardive dyskinesia: a 6-month evaluation of patients from the European Schizophrenia Outpatient Health Outcomes (SOHO) Study.","volume":"66","author":"Tenback","year":"2005","journal-title":"J Clin Psychiatry"},{"issue":"suppl 1","key":"R9-6-20210128","first-page":"20","article-title":"Metabolic considerations in the use of antipsychotic medications: a review of recent evidence.","volume":"68","author":"Newcomer","year":"2007","journal-title":"J Clin Psychiatry"},{"key":"R10-6-20210128","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/JCP.0b013e3181929f94","article-title":". Mortality rates among patients with schizophrenia and tardive dyskinesia.","volume":"29","author":"Chong","year":"2009","journal-title":"J Clin Psychopharmacol"},{"key":"R11-6-20210128","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/00004714-200004000-00011","article-title":"Tardive dyskinesia associated with higher mortality in psychiatric patients: results of a meta-analysis of seven independent studies.","volume":"20","author":"Ballesteros","year":"2000","journal-title":"J Clin Psychopharmacol"},{"key":"R12-6-20210128","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.4088\/JCP.v66n0905","article-title":". Clozapine, diabetes mellitus, hyperlipidemia, and cardiovascular risks and mortality: results of a 10-year naturalistic study.","volume":"66","author":"Henderson","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"R13-6-20210128","first-page":"723","article-title":"Harbo BT, et al..","volume":"56","author":"Ronning","year":"2000","journal-title":"Different versions of the anatomical therapeutic chemical classification system and the defined daily doseare drug utilisation data comparable Eur J Clin Pharmacol"},{"key":"R14-6-20210128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.schres.2009.03.005","article-title":"Schizophrenia, just the facts 4. Clinical features and conceptualization.","volume":"110","author":"Tandon","year":"2009","journal-title":"Schizophr Res"},{"key":"R15-6-20210128","doi-asserted-by":"crossref","first-page":"472","DOI":"10.4088\/JCP.v69n0320","article-title":". Major changes in glucose metabolism, including new-onset diabetes, within 3 months after initiation of or switch to atypical antipsychotic medication in patients with schizophrenia and schizoaffective disorder.","volume":"69","author":"van Winkel","year":"2008","journal-title":"J Clin Psychiatry"},{"key":"R16-6-20210128","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(08)61764-X","article-title":". Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis.","volume":"373","author":"Leucht","year":"2009","journal-title":"Lancet"},{"key":"R17-6-20210128","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1192\/bjp.177.3.212","article-title":"Causes of the excess mortality of schizophrenia.","volume":"177","author":"Brown","year":"2000","journal-title":"Br J Psychiatry"},{"key":"R18-6-20210128","first-page":"575","article-title":"Burton SC, et al..","volume":"40","author":"Barnes","year":"2006","journal-title":"Smoking and schizophrenia: is symptom profile related to smoking and which antipsychotic medication is of benefit in reducing cigarette use Aust N Z J Psychiatry"},{"key":"R19-6-20210128","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2165\/11588170-000000000-00000","article-title":"The role of antipsychotics in smoking and smoking cessation.","volume":"25","author":"Matthews","year":"2011","journal-title":"CNS Drugs"},{"key":"R20-6-20210128","first-page":"371","article-title":". Smoking and schizophrenia.","volume":"21","author":"Sagud","year":"2009","journal-title":"Psychiatr Danub"},{"key":"R21-6-20210128","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1176\/appi.ajp.161.3.414","article-title":"Lower risk for tardive dyskinesia associated with second-generation antipsychotics: a systematic review of 1-year studies.","volume":"161","author":"Correll","year":"2004","journal-title":"Am J Psychiatry"},{"key":"R22-6-20210128","doi-asserted-by":"crossref","first-page":"70","DOI":"10.2302\/kjm.38.70","article-title":". Mortality rate of schizophrenic patients with tardive dyskinesia during 10 years: a controlled study.","volume":"38","author":"Yagi","year":"1989","journal-title":"Keio J Med"},{"key":"R23-6-20210128","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1600-0447.1987.tb02754.x","article-title":"Morbidity and mortality in tardive dyskinesia: associations in chronic schizophrenia.","volume":"75","author":"Youssef","year":"1987","journal-title":"Acta Psychiatr Scand"},{"key":"R24-6-20210128","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1080\/j.1440-1614.2006.01920.x","article-title":". Antipsychotic medication dispensing and associated odds ratios of death in elderly veterans and war widows, 2001.","volume":"40","author":"Hollis","year":"2006","journal-title":"Aust N Z J Psychiatry"},{"key":"R25-6-20210128","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/01.nmd.0000105996.62105.07","article-title":". Serious cardiovascular events and mortality among patients with schizophrenia.","volume":"192","author":"Enger","year":"2004","journal-title":"J Nervous Mental Dis"},{"key":"R26-6-20210128","doi-asserted-by":"crossref","first-page":"103","DOI":"10.4088\/JCP.08m04818yel","article-title":". Antipsychotic polypharmacy and risk of death from natural causes in patients with schizophrenia: a population-based nested case-control study.","volume":"71","author":"Baandrup","year":"2010","journal-title":"J Clin Psychiatry"},{"issue":"suppl 2","key":"R27-6-20210128","first-page":"15S","article-title":"Metabolic issues and cardiovascular disease in patients with psychiatric disorders.","volume":"118","author":"Casey","year":"2005","journal-title":"Am J Med"},{"key":"R28-6-20210128","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1001\/jama.2010.410","article-title":". Anticonvulsant medications and the risk of suicide, attempted suicide, or violent death.","volume":"303","author":"Patorno","year":"2010","journal-title":"JAMA"},{"key":"R29-6-20210128","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/01.pra.0000336753.11943.7c","article-title":"Safety evaluation of the concomitant use of clozapine and benzodiazepines: a retrospective, cross-sectional chart review.","volume":"14","author":"Bitter","year":"2008","journal-title":"J Psychiatr Pract"},{"key":"R30-6-20210128","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1002\/pds.1579","article-title":". Association between medication and risk of suicide, attempted suicide and death in nationwide cohort of suicidal patients with schizophrenia.","volume":"17","author":"Haukka","year":"2008","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"R31-6-20210128","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.schres.2009.12.029","article-title":"Do antipsychotic medications reduce or increase mortality in schizophrenia A critical appraisal of the FIN-11 study.","volume":"117","author":"De Hert","year":"2010","journal-title":"Schizophr Res"},{"key":"R32-6-20210128","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.schres.2008.01.028","article-title":". Typical and atypical antipsychotics differentially affect long-term incidence rates of the metabolic syndrome in first-episode patients with schizophrenia: a retrospective chart review.","volume":"101","author":"De Hert","year":"2008","journal-title":"Schizophr Res"},{"key":"R33-6-20210128","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1097\/chi.0b013e318040b25f","article-title":"Weight gain and metabolic effects of mood stabilizers and antipsychotics in pediatric bipolar disorder: a systematic review and pooled analysis of short-term trials.","volume":"46","author":"Correll","year":"2007","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"R34-6-20210128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.schres.2010.05.025","article-title":"Schizophrenia, just the facts 5. Treatment and prevention. Past, present, and future.","volume":"122","author":"Tandon","year":"2010","journal-title":"Schizophr Res"},{"key":"R35-6-20210128","first-page":"1907","article-title":"Randomized trials or observational tribulations N Engl J Med.","volume":"342","author":"Pocock","year":"2000","journal-title":""},{"key":"R36-6-20210128","doi-asserted-by":"crossref","first-page":"726","DOI":"10.2105\/AJPH.86.5.726","article-title":"Adjusting for multiple testing when reporting research results: the Bonferroni vs Holm methods.","volume":"86","author":"Aickin","year":"1996","journal-title":"Am J Public Health"}],"container-title":["Journal of Clinical Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00004714-201202000-00006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:30:32Z","timestamp":1786048232000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00004714-201202000-00006"}},"subtitle":["A Prospective Cohort Study"],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/jcp.0b013e31823f3c43","relation":{},"ISSN":["0271-0749"],"issn-type":[{"value":"0271-0749","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]}}}